Literature DB >> 12209133

Coeliac disease: dissecting a complex inflammatory disorder.

Ludvig M Sollid1.   

Abstract

The disease mechanisms of complex inflammatory disorders are difficult to define because of extensive interactions between genetic and environmental factors. Coeliac disease is a typical complex inflammatory disorder, but this disease is unusual in that crucial genetic and environmental factors have been identified. This knowledge has allowed functional studies of the predisposing HLA molecules, the identification of antigenic epitopes and detailed studies of disease-relevant T cells in coeliac disease. This dissection of the pathogenic mechanisms of coeliac disease has uncovered principles that are relevant to other chronic inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209133     DOI: 10.1038/nri885

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  232 in total

1.  PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage.

Authors:  Maria Paola Simula; Renato Cannizzaro; Vincenzo Canzonieri; Alessandro Pavan; Stefania Maiero; Giuseppe Toffoli; Valli De Re
Journal:  Mol Med       Date:  2010-03-03       Impact factor: 6.354

2.  Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients.

Authors:  Raffaella Di Cagno; Maria De Angelis; Salvatore Auricchio; Luigi Greco; Charmaine Clarke; Massimo De Vincenzi; Claudio Giovannini; Massimo D'Archivio; Francesca Landolfo; Giampaolo Parrilli; Fabio Minervini; Elke Arendt; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

3.  Gliadin peptide specific intestinal T cells in coeliac disease.

Authors:  K E A Lundin; L M Sollid
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

Review 4.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

5.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Authors:  Chu-Young Kim; Hanne Quarsten; Elin Bergseng; Chaitan Khosla; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

Review 6.  Targeted modification of wheat grain protein to reduce the content of celiac causing epitopes.

Authors:  C Osorio; N Wen; R Gemini; R Zemetra; D von Wettstein; S Rustgi
Journal:  Funct Integr Genomics       Date:  2012-06-26       Impact factor: 3.410

7.  Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody.

Authors:  Shahrooz Rashtak; Shadi Rashtak; Melissa R Snyder; Sean J Pittock; Tsung-Teh Wu; Manish J Gandhi; Joseph A Murray
Journal:  J Neuroimmunol       Date:  2010-11-06       Impact factor: 3.478

8.  Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells.

Authors:  S M Stenman; K Lindfors; J I Venäläinen; A Hautala; P T Männistö; J A Garcia-Horsman; A Kaukovirta-Norja; S Auriola; T Mauriala; M Mäki; K Kaukinen
Journal:  Clin Exp Immunol       Date:  2010-06-15       Impact factor: 4.330

9.  In situ detection of active transglutaminases for keratinocyte type (TGase 1) and tissue type (TGase 2) using fluorescence-labeled highly reactive substrate peptides.

Authors:  Miho Itoh; Tadafumi Kawamoto; Hideki Tatsukawa; Soichi Kojima; Kiyofumi Yamanishi; Kiyotaka Hitomi
Journal:  J Histochem Cytochem       Date:  2011-02       Impact factor: 2.479

10.  T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac disease.

Authors:  Jan Petersen; Veronica Montserrat; Jorge R Mujico; Khai Lee Loh; Dennis X Beringer; Menno van Lummel; Allan Thompson; M Luisa Mearin; Joachim Schweizer; Yvonne Kooy-Winkelaar; Jeroen van Bergen; Jan W Drijfhout; Wan-Ting Kan; Nicole L La Gruta; Robert P Anderson; Hugh H Reid; Frits Koning; Jamie Rossjohn
Journal:  Nat Struct Mol Biol       Date:  2014-04-28       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.